A 42-year-old Indian male presents with epigastric pain and dyspepsia for 6 weeks. Upper endoscopy reveals the appearance shown in the diagram — the structure marked **A** shows nodular erythematous antral mucosa with erosions. Rapid urease test is positive. The patient has failed triple therapy with PPI, clarithromycin, and amoxicillin administered 3 months ago. Which of the following is the most appropriate next-line eradication regimen for this refractory H. pylori infection?
A. PPI + clarithromycin + metronidazole for 14 days
B. PPI + bismuth subsalicylate + metronidazole + tetracycline for 14 days
C. PPI + clarithromycin + amoxicillin for 21 days
D. PPI + levofloxacin + amoxicillin for 10 days
Explanation
Why option 2 (PPI + bismuth subsalicylate + metronidazole + tetracycline for 14 days) is correct
The endoscopic finding of nodular erythematous antral mucosa with erosions (marked A) is a classic presentation of H. pylori-associated chronic gastritis and is the clinical context for this refractory infection scenario. According to Maastricht VI/Florence Consensus 2022 and ACG guidelines, after FAILURE of clarithromycin-based triple therapy, the preferred salvage regimen is BISMUTH QUADRUPLE THERAPY: PPI BID + bismuth subsalicylate/subcitrate QID + metronidazole 500 mg TID + tetracycline 500 mg QID for 14 days. This regimen avoids repeating clarithromycin (to which resistance has already emerged) and provides synergistic activity against resistant strains.
Why each distractor is wrong
Option 1 (PPI + clarithromycin + metronidazole): This repeats clarithromycin, the antibiotic to which the organism has already demonstrated resistance after triple therapy failure. Guidelines explicitly state "never repeat the same antibiotics" in salvage regimens.
Option 3 (PPI + clarithromycin + amoxicillin for 21 days): This is the original failed triple therapy regimen. Extending the duration does not overcome clarithromycin resistance and violates the principle of switching to a different antibiotic class after first-line failure.
Option 4 (PPI + levofloxacin + amoxicillin for 10 days): While levofloxacin-based triple therapy is an acceptable alternative salvage regimen per guidelines, it is not the preferred first-line salvage after triple therapy failure. Bismuth quadruple therapy is preferred, and 10 days is insufficient duration (standard is 14 days).
High-YieldNEET PG
After H. pylori triple therapy failure, always switch to bismuth quadruple therapy for 14 days — never repeat the same antibiotics.
Maastricht VI/Florence Consensus 2022; ACG H. pylori Guideline 2017
Practice similar questions
Sign up free to access AI-powered MCQ practice with detailed explanations and adaptive learning.
